26 May 2013
Keywords: further, results, gissi-3, study, reported, marketletter, last
Article | 15 November 1993
As reported in the Marketletter last week, preliminary results from the GISSI-3 study of lisinopril (Zeneca's Zestril) and nitrates as ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.